tiprankstipranks
Trending News
More News >
Alphamab Oncology (HK:9966)
:9966
Hong Kong Market

Alphamab Oncology (9966) Revenue

Compare
1 Followers

Alphamab Oncology Revenue

Alphamab Oncology had a revenue of 319.44M in the quarter ending Jun 30, 2025, with -31.53%. This bring the company's revenue in the last twelve months to 785.96M, Decreased 22.79%. In the fiscal year ending Dec 31, 2024, Alphamab Oncology had annual revenue of 640.08M with 192.58% growth.
Revenue (ttm)
785.96M
Revenue Growth
206.58%
P/S Ratio
15.71
Revenue/Employee
HK$1,524,007
Employees
420
Market Cap
HK$10.05B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
640.08M421.31M+292.58%
Dec 31, 2023
218.77M51.93M+131.12%
Dec 31, 2022
166.84M20.82M+114.26%
Dec 31, 2021
146.02M-14,602,100,000.00%
Dec 31, 2020
-4.99M
Dec 31, 2019
4.99M5.73M-679.18%
Dec 31, 2018
-735.00K-1.96M-60.10%
Dec 31, 2017
1.22M